Eastern Cooperative Oncology Group: Head and Neck Neoplasms trials

The registry lists 11 Head and Neck Neoplasms studies with Eastern Cooperative Oncology Group as lead sponsor. 0 are open to participants now and 1 have results posted.

Phase 2 3Phase 3 5No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Cetuximab, Chemotherapy, and Radiation Therapy for Operable Stage III or IV Head and Neck CancerCompletedNCT00089297Phase 2Results posted
• Double Blind Phase III Trial of Effects of Low Dose 13-Cisretinoic Acid on Prevention of Second Primaries in Stages I-II Head and Neck CancerCompletedNCT03370367Phase 3
• Studying Biomarkers in Samples From Patients With Recurrent or Metastatic Head and Neck Cancer Treated on E1302 TrialCompletedNCT01619618
• Biomarkers in Tissue Samples From Patients With Recurrent or Metastatic Head and Neck Cancer Treated on ECOG-E1395 and ECOG-E3301CompletedNCT01487733
• Biomarkers in Patients With Metastatic or Recurrent Head and Neck Cancer Treated With Cisplatin and Cetuximab on ECOG-E5397CompletedNCT01466244
• Isotretinoin, Interferon Alfa, and Vitamin E in Treating Patients With Stage III or Stage IV Head and Neck CancerCompletedNCT00054561Phase 3
• Irinotecan and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Head and Neck CancerCompletedNCT00040807Phase 2
• Cisplatin With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic or Recurrent Head and Neck CancerCompletedNCT00003809Phase 3
• Methotrexate Compared With Paclitaxel in Treating Patients With Advanced Head and Neck CancerCompletedNCT00003592Phase 3
• Paclitaxel in Treating Patients With Advanced Head and Neck CancerCompletedNCT00002922Phase 2
• Combination Chemotherapy in Treating Patients With Advanced Head and Neck CancerCompletedNCT00002888Phase 3